SEDI Insider filing browser
Filter by Company
×
Filter by $CAD Amount
×
Filter by Filing Type
Filter by Insider
×
 
Date Issuer Insider Transaction Amount New Balance ⓘ
The balance of securities held by registered holder at the time of the transaction. Insiders may direct multiple registered holders and hold multiple security types.
Filed 2021-08-12 16:03
Tx date 2021-08-12
$BCT
BriaCell Therapeutics Corp.
Bondarenko, Jamieson
4 - Director of Issuer
Direct Ownership
Warrants
10 - Acquisition or disposition in the public market

+70,000 vol
103,333
Filed 2021-08-12 09:25
Tx date 2021-08-03
$BCT
BriaCell Therapeutics Corp.
Lustig, Marc
3 - 10% Security Holder of Issuer
Holder: L5 Capital Inc. (Control or Direction)
Common Shares
00 - Opening Balance-Initial SEDI Report
1,530,000
Filed 2021-07-08 14:31
Tx date 2021-07-08
$BCT
BriaCell Therapeutics Corp.
Bondarenko, Jamieson
4 - Director of Issuer
Direct Ownership
Warrants
10 - Acquisition or disposition in the public market

+30,000 vol
33,333
Filed 2021-06-22 17:04
Tx date 2019-10-10
$BCT
BriaCell Therapeutics Corp.
Embro-Pantalony, Vaughn
4 - Director of Issuer
Holder: Stratpath Management Inc (Indirect Ownership)
Common Shares
11 - Acquisition or disposition carried out privately
$99,999
+1,428,571 vol
$0.07 each
2,857,142
Filed 2021-06-22 17:02
Tx date 2020-01-03
$BCT
BriaCell Therapeutics Corp.
Embro-Pantalony, Vaughn
4 - Director of Issuer
Holder: Stratpath Management Inc (Indirect Ownership)
Common Shares
37 - Stock split or consolidation

-1,423,809 vol
1,433,333
Filed 2021-06-22 17:02
Tx date 2019-10-10
$BCT
BriaCell Therapeutics Corp.
Embro-Pantalony, Vaughn
4 - Director of Issuer
Holder: Stratpath Management Inc (Indirect Ownership)
Common Shares
11 - Acquisition or disposition carried out privately
$99,999
+1,428,571 vol
$0.07 each
Filed 2021-06-22 16:59
Tx date 2019-09-09
$BCT
BriaCell Therapeutics Corp.
Embro-Pantalony, Vaughn
4 - Director of Issuer
Holder: Stratpath Management Inc (Indirect Ownership)
Common Shares
11 - Acquisition or disposition carried out privately
$99,999
+1,428,571 vol
$0.07 each
1,428,571
Filed 2021-06-22 16:48
Tx date 2020-01-03
$BCT
BriaCell Therapeutics Corp.
Embro-Pantalony, Vaughn
4 - Director of Issuer
Holder: Stratpath Management Inc (Indirect Ownership)
Common Shares
37 - Stock split or consolidation

-1,423,809 vol
1,433,333
Filed 2021-06-22 16:47
Tx date 2019-10-10
$BCT
BriaCell Therapeutics Corp.
Embro-Pantalony, Vaughn
4 - Director of Issuer
Holder: Stratpath Management Inc (Indirect Ownership)
Common Shares
11 - Acquisition or disposition carried out privately
$99,999
+1,428,571 vol
$0.07 each
2,857,142
Filed 2021-06-22 16:47
Tx date 2019-10-10
$BCT
BriaCell Therapeutics Corp.
Embro-Pantalony, Vaughn
4 - Director of Issuer
Holder: Stratpath Management Inc (Indirect Ownership)
Common Shares
11 - Acquisition or disposition carried out privately
$99,999
+1,428,571 vol
$0.07 each
Filed 2021-06-22 16:45
Tx date 2019-03-15
$BCT
BriaCell Therapeutics Corp.
Embro-Pantalony, Vaughn
4 - Director of Issuer
Holder: Stratpath Management Inc (Indirect Ownership)
Common Shares
00 - Opening Balance-Initial SEDI Report
Filed 2020-01-03 15:55
Tx date 2020-01-03
$BCT
BriaCell Therapeutics Corp.
Embro-Pantalony, Vaughn
4 - Director of Issuer
Direct Ownership
Common Shares
37 - Stock split or consolidation

-1,423,809 vol
Filed 2019-09-11 11:42
Tx date 2019-09-09
$BCT
BriaCell Therapeutics Corp.
Embro-Pantalony, Vaughn
4 - Director of Issuer
Direct Ownership
Common Shares
11 - Acquisition or disposition carried out privately
$99,999
+1,428,571 vol
$0.07 each
Filed 2021-04-26 11:01
Tx date 2021-04-23
$BCT
BriaCell Therapeutics Corp.
WILLIAMS, WILLIAM
4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
Common Shares
10 - Acquisition or disposition in the public market
$17,487
+5,715 vol
$3.06 each
149,636
Filed 2021-04-26 11:00
Tx date 2021-04-23
$BCT
BriaCell Therapeutics Corp.
WILLIAMS, WILLIAM
4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
Common Shares
10 - Acquisition or disposition in the public market
$3,672
+1,208 vol
$3.04 each
143,921
Filed 2021-04-26 11:00
Tx date 2021-04-23
$BCT
BriaCell Therapeutics Corp.
WILLIAMS, WILLIAM
4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
Common Shares
10 - Acquisition or disposition in the public market
$6,420
+2,000 vol
$3.21 each
142,713
Filed 2021-04-26 10:58
Tx date 2021-04-23
$BCT
BriaCell Therapeutics Corp.
WILLIAMS, WILLIAM
4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
Common Shares
10 - Acquisition or disposition in the public market
$117,600
+36,750 vol
$3.20 each
140,713
Filed 2021-04-26 10:58
Tx date 2021-04-23
$BCT
BriaCell Therapeutics Corp.
WILLIAMS, WILLIAM
4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
Common Shares
10 - Acquisition or disposition in the public market
$8,772
+2,750 vol
$3.19 each
103,963
Filed 2021-04-26 10:57
Tx date 2021-04-23
$BCT
BriaCell Therapeutics Corp.
WILLIAMS, WILLIAM
4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
Common Shares
10 - Acquisition or disposition in the public market
$9,856
+3,200 vol
$3.08 each
101,213
Filed 2021-04-26 10:57
Tx date 2021-04-23
$BCT
BriaCell Therapeutics Corp.
WILLIAMS, WILLIAM
4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
Common Shares
10 - Acquisition or disposition in the public market
$17,105
+5,500 vol
$3.11 each
98,013
Filed 2021-04-26 10:56
Tx date 2021-04-23
$BCT
BriaCell Therapeutics Corp.
WILLIAMS, WILLIAM
4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
Common Shares
10 - Acquisition or disposition in the public market
$11,005
+3,585 vol
$3.07 each
92,513
Filed 2021-04-26 10:55
Tx date 2021-04-23
$BCT
BriaCell Therapeutics Corp.
WILLIAMS, WILLIAM
4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
Common Shares
10 - Acquisition or disposition in the public market
$1,334
+425 vol
$3.14 each
88,928
Filed 2021-04-26 10:55
Tx date 2021-04-23
$BCT
BriaCell Therapeutics Corp.
WILLIAMS, WILLIAM
4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
Common Shares
10 - Acquisition or disposition in the public market
$17,050
+5,500 vol
$3.10 each
88,503
Filed 2021-04-26 10:54
Tx date 2021-04-23
$BCT
BriaCell Therapeutics Corp.
WILLIAMS, WILLIAM
4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
Common Shares
10 - Acquisition or disposition in the public market
$626.00
+200 vol
$3.13 each
83,003
Filed 2021-04-26 10:54
Tx date 2021-04-23
$BCT
BriaCell Therapeutics Corp.
WILLIAMS, WILLIAM
4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
Common Shares
10 - Acquisition or disposition in the public market
$12,243
+3,850 vol
$3.18 each
82,803
Filed 2021-04-26 10:53
Tx date 2021-04-23
$BCT
BriaCell Therapeutics Corp.
WILLIAMS, WILLIAM
4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
Common Shares
11 - Acquisition or disposition carried out privately
$17,472
+5,600 vol
$3.12 each
78,953
Filed 2021-04-26 10:53
Tx date 2021-04-23
$BCT
BriaCell Therapeutics Corp.
WILLIAMS, WILLIAM
4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
Common Shares
10 - Acquisition or disposition in the public market
$1,195
+392 vol
$3.05 each
73,353
Filed 2021-04-26 10:52
Tx date 2021-04-23
$BCT
BriaCell Therapeutics Corp.
WILLIAMS, WILLIAM
4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
Common Shares
10 - Acquisition or disposition in the public market
$4,944
+1,600 vol
$3.09 each
72,961
Filed 2021-04-26 10:51
Tx date 2021-04-23
$BCT
BriaCell Therapeutics Corp.
WILLIAMS, WILLIAM
4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
Common Shares
10 - Acquisition or disposition in the public market
$2,133
+675 vol
$3.16 each
71,361
Filed 2021-04-26 10:50
Tx date 2021-04-23
$BCT
BriaCell Therapeutics Corp.
WILLIAMS, WILLIAM
4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
Common Shares
10 - Acquisition or disposition in the public market
$10,144
+3,200 vol
$3.17 each
70,686
Filed 2021-04-26 10:50
Tx date 2021-04-23
$BCT
BriaCell Therapeutics Corp.
WILLIAMS, WILLIAM
4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
Common Shares
10 - Acquisition or disposition in the public market
$315.00
+100 vol
$3.15 each
67,486
Filed 2021-04-26 10:49
Tx date 2021-04-23
$BCT
BriaCell Therapeutics Corp.
WILLIAMS, WILLIAM
4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
Common Shares
10 - Acquisition or disposition in the public market
$1,562
+500 vol
$3.13 each
67,386
Filed 2021-04-26 10:48
Tx date 2021-04-23
$BCT
BriaCell Therapeutics Corp.
WILLIAMS, WILLIAM
4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
Common Shares
10 - Acquisition or disposition in the public market
$259,835
+82,750 vol
$3.14 each
Filed 2021-04-23 18:49
Tx date 2021-04-23
$BCT
BriaCell Therapeutics Corp.
WILLIAMS, WILLIAM
4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
Common Shares
10 - Acquisition or disposition in the public market
$259,835
+82,750 vol
$3.14 each
Filed 2021-04-23 18:46
Tx date 2021-04-23
$BCT
BriaCell Therapeutics Corp.
WILLIAMS, WILLIAM
4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
Common Shares
10 - Acquisition or disposition in the public market
$259,835
+82,750 vol
$3.14 each
Filed 2021-04-23 18:49
Tx date 2021-04-23
$BCT
BriaCell Therapeutics Corp.
WILLIAMS, WILLIAM
4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
Common Shares
10 - Acquisition or disposition in the public market
$259,835
+82,750 vol
$3.14 each
149,636
Filed 2021-04-23 18:46
Tx date 2021-04-23
$BCT
BriaCell Therapeutics Corp.
WILLIAMS, WILLIAM
4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
Common Shares
10 - Acquisition or disposition in the public market
$259,835
+82,750 vol
$3.14 each
Filed 2021-04-23 17:21
Tx date 2021-04-23
$BCT
BriaCell Therapeutics Corp.
Levin, Gadi
5 - Senior Officer of Issuer
Direct Ownership
Common Shares
10 - Acquisition or disposition in the public market
$7,718
+2,000 vol
$3.86 each
2,810
Filed 2021-04-23 17:17
Tx date 2021-03-29
$BCT
BriaCell Therapeutics Corp.
Levin, Gadi
5 - Senior Officer of Issuer
Direct Ownership
Options
50 - Grant of options
$318,000
+75,000 vol
$4.24 each
75,667
Filed 2021-04-23 17:16
Tx date 2021-04-23
$BCT
BriaCell Therapeutics Corp.
Levin, Gadi
5 - Senior Officer of Issuer
Direct Ownership
Options
52 - Expiration of options

-667 vol
75,000
Filed 2021-03-31 14:00
Tx date 2021-03-29
$BCT
BriaCell Therapeutics Corp.
Schmieg, Martin
4 - Director of Issuer
Direct Ownership
Options
50 - Grant of options
$106,000
+25,000 vol
$4.24 each
25,000
Filed 2021-03-31 13:59
Tx date 2021-03-29
$BCT
BriaCell Therapeutics Corp.
Schmieg, Martin
4 - Director of Issuer
Direct Ownership
Options
52 - Expiration of options

-500,000 vol
0
Filed 2021-03-30 17:58
Tx date 2021-03-29
$BCT
BriaCell Therapeutics Corp.
Bondarenko, Jamieson
3 - 10% Security Holder of Issuer, 4 - Director of Issuer
Direct Ownership
Options
50 - Grant of options
$636,000
+150,000 vol
$4.24 each
156,667
Filed 2021-03-30 14:33
Tx date 2021-03-29
$BCT
BriaCell Therapeutics Corp.
WILLIAMS, WILLIAM
4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
Options
50 - Grant of options
$848,000
+200,000 vol
$4.24 each
200,000
Filed 2021-03-30 14:32
Tx date 2021-03-29
$BCT
BriaCell Therapeutics Corp.
WILLIAMS, WILLIAM
4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
Options
52 - Expiration of options

-2,500 vol
0
Filed 2021-03-30 14:10
Tx date 2021-03-29
$BCT
BriaCell Therapeutics Corp.
WISEMAN, CHARLES LOUIS
6 - Director or Senior Officer of 10% Security Holder
Direct Ownership
Options
50 - Grant of options
$318,000
+75,000 vol
$4.24 each
75,000
Filed 2021-03-30 14:09
Tx date 2021-03-29
$BCT
BriaCell Therapeutics Corp.
WISEMAN, CHARLES LOUIS
6 - Director or Senior Officer of 10% Security Holder
Direct Ownership
Options
52 - Expiration of options

-1,667 vol
0
Filed 2021-03-30 13:58
Tx date 2021-03-29
$BCT
BriaCell Therapeutics Corp.
Embro-Pantalony, Vaughn
4 - Director of Issuer
Direct Ownership
Options
50 - Grant of options
$106,000
+25,000 vol
$4.24 each
25,000
Filed 2021-03-30 13:57
Tx date 2019-03-15
$BCT
BriaCell Therapeutics Corp.
Embro-Pantalony, Vaughn
4 - Director of Issuer
Direct Ownership
Options
00 - Opening Balance-Initial SEDI Report
Filed 2021-03-30 13:32
Tx date 2021-03-29
$BCT
BriaCell Therapeutics Corp.
Taub, Rebecca Anne
4 - Director of Issuer
Direct Ownership
Options
50 - Grant of options
$42,400
+10,000 vol
$4.24 each
10,000
Filed 2021-03-30 13:30
Tx date 2019-03-07
$BCT
BriaCell Therapeutics Corp.
Taub, Rebecca Anne
4 - Director of Issuer
Direct Ownership
Options
00 - Opening Balance-Initial SEDI Report
Filed 2020-01-14 15:47
Tx date 2020-01-03
$BCT
BriaCell Therapeutics Corp.
WILLIAMS, WILLIAM
4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
Common Shares
37 - Stock split or consolidation

-20,052,392 vol
66,886
Filed 2020-01-03 15:44
Tx date 2020-01-03
$BCT
BriaCell Therapeutics Corp.
WILLIAMS, WILLIAM
4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
Common Shares
37 - Stock split or consolidation

-20,052,214 vol
Filed 2020-01-06 18:58
Tx date 2020-01-02
$BCT
BriaCell Therapeutics Corp.
Bondarenko, Jamieson
3 - 10% Security Holder of Issuer, 4 - Director of Issuer
Direct Ownership
Warrants
37 - Stock split or consolidation

-996,667 vol
3,333
Filed 2020-01-06 18:56
Tx date 2020-01-02
$BCT
BriaCell Therapeutics Corp.
Bondarenko, Jamieson
3 - 10% Security Holder of Issuer, 4 - Director of Issuer
Direct Ownership
Options
37 - Stock split or consolidation

-1,993,333 vol
6,667
Filed 2020-01-06 18:53
Tx date 2020-01-02
$BCT
BriaCell Therapeutics Corp.
Bondarenko, Jamieson
3 - 10% Security Holder of Issuer, 4 - Director of Issuer
Direct Ownership
Common Shares
37 - Stock split or consolidation

-35,836,846 vol
119,856
Filed 2020-01-05 13:00
Tx date 2020-01-02
$BCT
BriaCell Therapeutics Corp.
Levin, Gadi
5 - Senior Officer of Issuer
Direct Ownership
Warrants
37 - Stock split or consolidation

-99,667 vol
333
Filed 2020-01-05 12:59
Tx date 2020-01-02
$BCT
BriaCell Therapeutics Corp.
Levin, Gadi
5 - Senior Officer of Issuer
Direct Ownership
Options
37 - Stock split or consolidation

-199,333 vol
667
Filed 2020-01-05 12:56
Tx date 2020-01-02
$BCT
BriaCell Therapeutics Corp.
Levin, Gadi
5 - Senior Officer of Issuer
Direct Ownership
Common Shares
37 - Stock split or consolidation

-242,047 vol
810
Filed 2020-01-03 15:55
Tx date 2020-01-03
$BCT
BriaCell Therapeutics Corp.
Embro-Pantalony, Vaughn
4 - Director of Issuer
Direct Ownership
Common Shares
37 - Stock split or consolidation

-1,423,809 vol
4,762
Filed 2020-01-03 15:53
Tx date 2019-10-15
$BCT
BriaCell Therapeutics Corp.
Embro-Pantalony, Vaughn
4 - Director of Issuer
Direct Ownership
Common Shares
11 - Acquisition or disposition carried out privately
$99,999
+1,428,571 vol
$0.07 each
Filed 2020-01-03 15:44
Tx date 2020-01-03
$BCT
BriaCell Therapeutics Corp.
WILLIAMS, WILLIAM
4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
Common Shares
37 - Stock split or consolidation

-20,052,214 vol
67,064
Filed 2020-01-03 15:44
Tx date 2020-01-03
$BCT
BriaCell Therapeutics Corp.
WILLIAMS, WILLIAM
4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
Warrants
37 - Stock split or consolidation

-643,448 vol
2,152
Filed 2020-01-03 15:42
Tx date 2020-01-03
$BCT
BriaCell Therapeutics Corp.
WILLIAMS, WILLIAM
4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
Options
37 - Stock split or consolidation

-747,500 vol
2,500
Filed 2020-01-03 15:39
Tx date 2020-01-03
$BCT
BriaCell Therapeutics Corp.
WISEMAN, CHARLES LOUIS
6 - Director or Senior Officer of 10% Security Holder
Direct Ownership
Common Shares
37 - Stock split or consolidation

-13,266,917 vol
44,370
Filed 2020-01-03 15:38
Tx date 2020-01-03
$BCT
BriaCell Therapeutics Corp.
WISEMAN, CHARLES LOUIS
6 - Director or Senior Officer of 10% Security Holder
Holder: Wiseman Cancer Research Foundation (Indirect Ownership)
Common Shares
37 - Stock split or consolidation

-69,767 vol
233
Filed 2020-01-03 15:36
Tx date 2020-01-03
$BCT
BriaCell Therapeutics Corp.
WISEMAN, CHARLES LOUIS
6 - Director or Senior Officer of 10% Security Holder
Holder: Wiseman Cancer Research Foundation (Indirect Ownership)
Common Shares
37 - Stock split or consolidation

-6,977 vol
Filed 2020-01-03 15:34
Tx date 2020-01-03
$BCT
BriaCell Therapeutics Corp.
WISEMAN, CHARLES LOUIS
6 - Director or Senior Officer of 10% Security Holder
Direct Ownership
Options
37 - Stock split or consolidation
$-22,424,985
-498,333 vol
$45.00 each
1,667
Filed 2020-01-03 14:19
Tx date 2020-01-03
$BCT
BriaCell Therapeutics Corp.
WILLIAMS, WILLIAM
4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
Options
52 - Expiration of options

-632,000 vol
750,000
Filed 2019-10-16 11:58
Tx date 2019-10-15
$BCT
BriaCell Therapeutics Corp.
Embro-Pantalony, Vaughn
4 - Director of Issuer
Direct Ownership
Common Shares
11 - Acquisition or disposition carried out privately
$99,999
+1,428,571 vol
$0.07 each
Filed 2019-11-15 17:09
Tx date 2019-02-09
$BCT
BriaCell Therapeutics Corp.
Bondarenko, Jamieson
3 - 10% Security Holder of Issuer, 4 - Director of Issuer
Direct Ownership
Warrants
00 - Opening Balance-Initial SEDI Report
2,000,000
Filed 2019-11-15 17:07
Tx date 2019-11-15
$BCT
BriaCell Therapeutics Corp.
Bondarenko, Jamieson
3 - 10% Security Holder of Issuer, 4 - Director of Issuer
Direct Ownership
Warrants
55 - Expiration of warrants

-1,000,000 vol
1,000,000
Filed 2019-11-15 15:02
Tx date 2019-02-09
$BCT
BriaCell Therapeutics Corp.
Bondarenko, Jamieson
3 - 10% Security Holder of Issuer, 4 - Director of Issuer
Direct Ownership
Warrants
00 - Opening Balance-Initial SEDI Report
-1,000,000
Filed 2019-11-15 15:02
Tx date 2019-02-09
$BCT
BriaCell Therapeutics Corp.
Bondarenko, Jamieson
3 - 10% Security Holder of Issuer, 4 - Director of Issuer
Direct Ownership
Warrants
00 - Opening Balance-Initial SEDI Report
Filed 2019-11-15 15:02
Tx date 2019-02-09
$BCT
BriaCell Therapeutics Corp.
Bondarenko, Jamieson
3 - 10% Security Holder of Issuer, 4 - Director of Issuer
Direct Ownership
Warrants
00 - Opening Balance-Initial SEDI Report
Filed 2019-11-15 15:02
Tx date 2019-02-09
$BCT
BriaCell Therapeutics Corp.
Bondarenko, Jamieson
3 - 10% Security Holder of Issuer, 4 - Director of Issuer
Direct Ownership
Warrants
00 - Opening Balance-Initial SEDI Report
Filed 2019-11-15 14:59
Tx date 2019-02-09
$BCT
BriaCell Therapeutics Corp.
Bondarenko, Jamieson
3 - 10% Security Holder of Issuer, 4 - Director of Issuer
Direct Ownership
Warrants
00 - Opening Balance-Initial SEDI Report
Filed 2019-11-15 13:32
Tx date 2019-02-09
$BCT
BriaCell Therapeutics Corp.
Bondarenko, Jamieson
3 - 10% Security Holder of Issuer, 4 - Director of Issuer
Direct Ownership
Warrants
00 - Opening Balance-Initial SEDI Report
1,000,000
Filed 2019-11-15 13:32
Tx date 2019-02-09
$BCT
BriaCell Therapeutics Corp.
Bondarenko, Jamieson
3 - 10% Security Holder of Issuer, 4 - Director of Issuer
Direct Ownership
Warrants
00 - Opening Balance-Initial SEDI Report
Filed 2019-02-09 16:58
Tx date 2019-02-09
$BCT
BriaCell Therapeutics Corp.
Bondarenko, Jamieson
3 - 10% Security Holder of Issuer, 4 - Director of Issuer
Direct Ownership
Warrants
00 - Opening Balance-Initial SEDI Report
Filed 2019-02-09 16:58
Tx date 2019-02-09
$BCT
BriaCell Therapeutics Corp.
Bondarenko, Jamieson
3 - 10% Security Holder of Issuer, 4 - Director of Issuer
Direct Ownership
Warrants
00 - Opening Balance-Initial SEDI Report
Filed 2019-11-14 16:30
Tx date 2019-11-14
$BCT
BriaCell Therapeutics Corp.
WILLIAMS, WILLIAM
4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
Warrants
55 - Expiration of warrants

-2,806,041 vol
645,600
Filed 2019-10-16 11:59
Tx date 2019-10-15
$BCT
BriaCell Therapeutics Corp.
Bondarenko, Jamieson
3 - 10% Security Holder of Issuer, 4 - Director of Issuer
Direct Ownership
Common Shares
16 - Acquisition or disposition under a prospectus exemption
$150,003
+2,142,900 vol
$0.07 each
35,956,702
Filed 2019-10-16 11:58
Tx date 2019-10-15
$BCT
BriaCell Therapeutics Corp.
Embro-Pantalony, Vaughn
4 - Director of Issuer
Direct Ownership
Common Shares
11 - Acquisition or disposition carried out privately
$99,999
+1,428,571 vol
$0.07 each
2,857,142
Filed 2019-10-16 11:53
Tx date 2019-10-15
$BCT
BriaCell Therapeutics Corp.
WILLIAMS, WILLIAM
4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
Common Shares
11 - Acquisition or disposition carried out privately
$149,999
+2,142,857 vol
$0.07 each
20,119,278
Filed 2019-09-12 10:28
Tx date 2019-09-09
$BCT
BriaCell Therapeutics Corp.
Bondarenko, Jamieson
3 - 10% Security Holder of Issuer, 4 - Director of Issuer
Direct Ownership
Common Shares
16 - Acquisition or disposition under a prospectus exemption
$220,801
+3,154,302 vol
$0.07 each
33,813,802
Filed 2019-09-11 11:48
Tx date 2019-09-09
$BCT
BriaCell Therapeutics Corp.
WILLIAMS, WILLIAM
4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
Common Shares
11 - Acquisition or disposition carried out privately
$450,000
+6,428,572 vol
$0.07 each
17,976,421
Filed 2019-09-11 11:48
Tx date 2019-09-09
$BCT
BriaCell Therapeutics Corp.
WILLIAMS, WILLIAM
4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
Common Shares
11 - Acquisition or disposition carried out privately
$7,000
+100,000 vol
$0.07 each
11,547,849
Filed 2019-09-11 11:42
Tx date 2019-09-09
$BCT
BriaCell Therapeutics Corp.
Embro-Pantalony, Vaughn
4 - Director of Issuer
Direct Ownership
Common Shares
11 - Acquisition or disposition carried out privately
$99,999
+1,428,571 vol
$0.07 each
1,428,571
Filed 2019-09-11 11:41
Tx date 2019-03-15
$BCT
BriaCell Therapeutics Corp.
Embro-Pantalony, Vaughn
4 - Director of Issuer
Direct Ownership
Common Shares
00 - Opening Balance-Initial SEDI Report
Filed 2019-09-10 15:27
Tx date 2019-09-09
$BCT
BriaCell Therapeutics Corp.
Levin, Gadi
5 - Senior Officer of Issuer
Direct Ownership
Common Shares
11 - Acquisition or disposition carried out privately
$9,999
+142,857 vol
$0.07 each
242,857
Filed 2019-08-02 13:26
Tx date 2019-05-31
$BCT
BriaCell Therapeutics Corp.
Bondarenko, Jamieson
3 - 10% Security Holder of Issuer, 4 - Director of Issuer
Direct Ownership
Common Shares
10 - Acquisition or disposition in the public market

+210,000 vol
Filed 2019-06-02 18:26
Tx date 2019-05-31
$BCT
BriaCell Therapeutics Corp.
Bondarenko, Jamieson
3 - 10% Security Holder of Issuer, 4 - Director of Issuer
Direct Ownership
Common Shares
10 - Acquisition or disposition in the public market

+210,000 vol
Filed 2019-06-11 17:44
Tx date 2019-06-11
$BCT
BriaCell Therapeutics Corp.
Bondarenko, Jamieson
3 - 10% Security Holder of Issuer, 4 - Director of Issuer
Direct Ownership
Common Shares
10 - Acquisition or disposition in the public market

+424,000 vol
30,869,500
Filed 2019-06-10 16:35
Tx date 2019-06-10
$BCT
BriaCell Therapeutics Corp.
Bondarenko, Jamieson
3 - 10% Security Holder of Issuer, 4 - Director of Issuer
Direct Ownership
Common Shares
10 - Acquisition or disposition in the public market

+576,000 vol
30,445,500
Filed 2019-06-10 09:23
Tx date 2019-06-05
$BCT
BriaCell Therapeutics Corp.
Bondarenko, Jamieson
3 - 10% Security Holder of Issuer, 4 - Director of Issuer
Direct Ownership
Common Shares
10 - Acquisition or disposition in the public market

+409,000 vol
29,869,500
Filed 2019-06-05 09:03
Tx date 2019-06-04
$BCT
BriaCell Therapeutics Corp.
Bondarenko, Jamieson
3 - 10% Security Holder of Issuer, 4 - Director of Issuer
Direct Ownership
Common Shares
10 - Acquisition or disposition in the public market

+286,000 vol
29,460,500
Filed 2019-06-04 07:18
Tx date 2019-06-03
$BCT
BriaCell Therapeutics Corp.
Bondarenko, Jamieson
3 - 10% Security Holder of Issuer, 4 - Director of Issuer
Direct Ownership
Common Shares
10 - Acquisition or disposition in the public market

+305,000 vol
29,174,500
Filed 2019-06-02 18:26
Tx date 2019-05-31
$BCT
BriaCell Therapeutics Corp.
Bondarenko, Jamieson
3 - 10% Security Holder of Issuer, 4 - Director of Issuer
Direct Ownership
Common Shares
10 - Acquisition or disposition in the public market

+210,000 vol
28,869,500
Filed 2019-05-21 13:29
Tx date 2019-05-17
$BCT
BriaCell Therapeutics Corp.
Bondarenko, Jamieson
3 - 10% Security Holder of Issuer, 4 - Director of Issuer
Direct Ownership
Common Shares
10 - Acquisition or disposition in the public market

+216,000 vol
28,659,500
Filed 2019-05-16 17:04
Tx date 2019-05-16
$BCT
BriaCell Therapeutics Corp.
Bondarenko, Jamieson
3 - 10% Security Holder of Issuer, 4 - Director of Issuer
Direct Ownership
Common Shares
10 - Acquisition or disposition in the public market

+332,000 vol
28,443,500
Filed 2019-05-16 17:03
Tx date 2019-05-15
$BCT
BriaCell Therapeutics Corp.
Bondarenko, Jamieson
3 - 10% Security Holder of Issuer, 4 - Director of Issuer
Direct Ownership
Common Shares
10 - Acquisition or disposition in the public market

+115,000 vol
28,111,500
Filed 2019-05-14 16:37
Tx date 2019-05-14
$BCT
BriaCell Therapeutics Corp.
Bondarenko, Jamieson
3 - 10% Security Holder of Issuer, 4 - Director of Issuer
Direct Ownership
Common Shares
10 - Acquisition or disposition in the public market

+20,000 vol
27,996,500
Filed 2019-05-13 16:12
Tx date 2019-05-13
$BCT
BriaCell Therapeutics Corp.
Bondarenko, Jamieson
3 - 10% Security Holder of Issuer, 4 - Director of Issuer
Direct Ownership
Common Shares
10 - Acquisition or disposition in the public market

+1,231,000 vol
27,976,500
Filed 2019-05-09 17:58
Tx date 2019-05-09
$BCT
BriaCell Therapeutics Corp.
Bondarenko, Jamieson
3 - 10% Security Holder of Issuer, 4 - Director of Issuer
Direct Ownership
Common Shares
10 - Acquisition or disposition in the public market

+5,000 vol
26,745,500
Filed 2019-04-18 12:14
Tx date 2019-04-18
$BCT
BriaCell Therapeutics Corp.
Bondarenko, Jamieson
3 - 10% Security Holder of Issuer, 4 - Director of Issuer
Direct Ownership
Common Shares
10 - Acquisition or disposition in the public market

+3,000,000 vol
26,740,500
Filed 2019-04-17 19:46
Tx date 2019-04-17
$BCT
BriaCell Therapeutics Corp.
Bondarenko, Jamieson
3 - 10% Security Holder of Issuer, 4 - Director of Issuer
Direct Ownership
Common Shares
10 - Acquisition or disposition in the public market

+200,000 vol
23,740,500
Filed 2019-04-12 12:44
Tx date 2019-04-12
$BCT
BriaCell Therapeutics Corp.
Bondarenko, Jamieson
4 - Director of Issuer
Direct Ownership
Common Shares
10 - Acquisition or disposition in the public market
$27,500
+250,000 vol
$0.11 each
23,540,500
Filed 2019-03-25
Tx date 2019-03-25
$BCT
BriaCell Therapeutics Corp.
Bondarenko, Jamieson
4 - Director of Issuer
Direct Ownership
Common Shares
16 - Acquisition or disposition under a prospectus exemption
$500,000
+5,000,000 vol
$0.10 each
23,290,500
Filed 2019-03-07
Tx date 2019-03-05
$BCT
BriaCell Therapeutics Corp.
Bondarenko, Jamieson
4 - Director of Issuer
Direct Ownership
Common Shares
10 - Acquisition or disposition in the public market

+150,000 vol
18,220,500
Filed 2019-03-07
Tx date 2019-03-06
$BCT
BriaCell Therapeutics Corp.
Bondarenko, Jamieson
4 - Director of Issuer
Direct Ownership
Common Shares
10 - Acquisition or disposition in the public market

+70,000 vol
18,290,500
Filed 2019-02-12
Tx date 2019-02-12
$BCT
BriaCell Therapeutics Corp.
Bondarenko, Jamieson
4 - Director of Issuer
Direct Ownership
Common Shares
10 - Acquisition or disposition in the public market

+2,000,000 vol
18,070,500
Filed 2019-02-09
Tx date 2019-02-09
$BCT
BriaCell Therapeutics Corp.
Bondarenko, Jamieson
4 - Director of Issuer
Direct Ownership
Common Shares
00 - Opening Balance-Initial SEDI Report
16,070,500
Filed 2019-02-09
Tx date 2019-02-09
$BCT
BriaCell Therapeutics Corp.
Bondarenko, Jamieson
4 - Director of Issuer
Direct Ownership
Options
00 - Opening Balance-Initial SEDI Report
2,000,000
Filed 2019-02-09
Tx date 2019-02-09
$BCT
BriaCell Therapeutics Corp.
Bondarenko, Jamieson
4 - Director of Issuer
Direct Ownership
Warrants
00 - Opening Balance-Initial SEDI Report
2,200,000
Filed 2018-06-14
Tx date 2018-06-14
$BCT
BriaCell Therapeutics Corp.
SHARAN, RAHOUL
4 - Director of Issuer
Holder: KJN Management Ltd (Indirect Ownership)
Common Shares
10 - Acquisition or disposition in the public market
$3,045
+21,000 vol
$0.145 each
100,000
Filed 2018-06-14
Tx date 2018-06-13
$BCT
BriaCell Therapeutics Corp.
SHARAN, RAHOUL
4 - Director of Issuer
Holder: KJN Management Ltd (Indirect Ownership)
Common Shares
10 - Acquisition or disposition in the public market
$11,455
+79,000 vol
$0.145 each
79,000
Filed 2018-03-29
Tx date 2018-03-19
$BCT
BriaCell Therapeutics Corp.
Levin, Gadi
5 - Senior Officer of Issuer
Direct Ownership
Common Shares
30 - Acquisition or disposition under a purchase/ownership plan
$1,000
+100,000 vol
$0.01 each
100,000
Filed 2018-03-29
Tx date 2018-03-19
$BCT
BriaCell Therapeutics Corp.
Levin, Gadi
5 - Senior Officer of Issuer
Direct Ownership
Warrants
30 - Acquisition or disposition under a purchase/ownership plan
$14,000
+100,000 vol
$0.14 each
100,000
Filed 2018-03-21
Tx date 2018-03-19
$BCT
BriaCell Therapeutics Corp.
Schmieg, Martin
4 - Director of Issuer
Direct Ownership
Common Shares
11 - Acquisition or disposition carried out privately
$10,000
+100,000 vol
$0.10 each
172,391
Filed 2018-03-21
Tx date 2018-03-19
$BCT
BriaCell Therapeutics Corp.
Schmieg, Martin
4 - Director of Issuer
Direct Ownership
Warrants
11 - Acquisition or disposition carried out privately
$14,000
+100,000 vol
$0.14 each
100,000
Filed 2018-03-21
Tx date 2016-05-10
$BCT
BriaCell Therapeutics Corp.
Schmieg, Martin
4 - Director of Issuer
Direct Ownership
Warrants
00 - Opening Balance-Initial SEDI Report
Filed 2018-03-20
Tx date 2018-03-19
$BCT
BriaCell Therapeutics Corp.
SHARAN, RAHOUL
4 - Director of Issuer
Direct Ownership
Common Shares
10 - Acquisition or disposition in the public market
$4,500
+37,500 vol
$0.12 each
1,476,878
Filed 2018-03-20
Tx date 2018-03-19
$BCT
BriaCell Therapeutics Corp.
SHARAN, RAHOUL
4 - Director of Issuer
Direct Ownership
Common Shares
11 - Acquisition or disposition carried out privately
$70,000
+500,000 vol
$0.14 each
1,439,378
Filed 2018-03-20
Tx date 2018-03-19
$BCT
BriaCell Therapeutics Corp.
Babaei, Saeid
4 - Director of Issuer
Direct Ownership
Warrants
53 - Grant of warrants
$15,000
+150,000 vol
$0.10 each
150,000
Filed 2018-03-20
Tx date 2014-11-25
$BCT
BriaCell Therapeutics Corp.
Babaei, Saeid
4 - Director of Issuer
Direct Ownership
Warrants
00 - Opening Balance-Initial SEDI Report
Filed 2018-03-20
Tx date 2014-11-25
$BCT
BriaCell Therapeutics Corp.
Babaei, Saeid
4 - Director of Issuer
Direct Ownership
Common Shares
00 - Opening Balance-Initial SEDI Report
Filed 2018-03-20
Tx date 2018-03-19
$BCT
BriaCell Therapeutics Corp.
Babaei, Saeid
4 - Director of Issuer
Direct Ownership
Common Shares
11 - Acquisition or disposition carried out privately
$21,000
+150,000 vol
$0.14 each
150,000
Filed 2018-03-20
Tx date 2018-03-19
$BCT
BriaCell Therapeutics Corp.
WILLIAMS, WILLIAM
4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
Warrants
53 - Grant of warrants
$64,560
+645,600 vol
$0.10 each
3,451,641
Filed 2018-03-20
Tx date 2018-03-19
$BCT
BriaCell Therapeutics Corp.
WILLIAMS, WILLIAM
4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
Common Shares
11 - Acquisition or disposition carried out privately
$90,384
+645,600 vol
$0.14 each
11,447,849
Filed 2018-03-20
Tx date 2018-03-19
$BCT
BriaCell Therapeutics Corp.
SHARAN, RAHOUL
4 - Director of Issuer
Direct Ownership
Warrants
53 - Grant of warrants
$50,000
+500,000 vol
$0.10 each
675,000
Filed 2018-03-20
Tx date 2016-04-29
$BCT
BriaCell Therapeutics Corp.
SHARAN, RAHOUL
4 - Director of Issuer
Direct Ownership
Warrants
11 - Acquisition or disposition carried out privately

+175,000 vol
175,000
Filed 2018-03-20
Tx date 2016-04-29
$BCT
BriaCell Therapeutics Corp.
SHARAN, RAHOUL
4 - Director of Issuer
Direct Ownership
Warrants
11 - Acquisition or disposition carried out privately

+175,000 vol
Filed 2018-03-20
Tx date 2018-03-19
$BCT
BriaCell Therapeutics Corp.
SHARAN, RAHOUL
4 - Director of Issuer
Direct Ownership
Common Shares
10 - Acquisition or disposition in the public market
$7,500
+62,500 vol
$0.12 each
1,539,378
Filed 2018-03-16
Tx date 2018-03-16
$BCT
BriaCell Therapeutics Corp.
SHARAN, RAHOUL
4 - Director of Issuer
Direct Ownership
Common Shares
10 - Acquisition or disposition in the public market
$-41,600
-320,000 vol
$0.13 each
Filed 2018-03-16
Tx date 2018-03-15
$BCT
BriaCell Therapeutics Corp.
SHARAN, RAHOUL
4 - Director of Issuer
Holder: KJN Management Ltd (Indirect Ownership)
Common Shares
10 - Acquisition or disposition in the public market
$-11,570
-89,000 vol
$0.13 each
0
Filed 2018-03-16
Tx date 2018-03-16
$BCT
BriaCell Therapeutics Corp.
SHARAN, RAHOUL
4 - Director of Issuer
Direct Ownership
Common Shares
10 - Acquisition or disposition in the public market
$-13,780
-106,000 vol
$0.13 each
939,378
Filed 2018-03-16
Tx date 2018-03-16
$BCT
BriaCell Therapeutics Corp.
SHARAN, RAHOUL
4 - Director of Issuer
Direct Ownership
Common Shares
10 - Acquisition or disposition in the public market
$-41,600
-320,000 vol
$0.13 each
Filed 2018-03-16
Tx date 2018-03-15
$BCT
BriaCell Therapeutics Corp.
SHARAN, RAHOUL
4 - Director of Issuer
Direct Ownership
Common Shares
10 - Acquisition or disposition in the public market
$-25,350
-195,000 vol
$0.13 each
1,045,378
Filed 2018-03-08
Tx date 2016-05-09
$BCT
BriaCell Therapeutics Corp.
Schmieg, Martin
4 - Director of Issuer
Direct Ownership
Options
50 - Grant of options
$127,500
+500,000 vol
$0.255 each
Filed 2018-03-08
Tx date 2018-03-01
$BCT
BriaCell Therapeutics Corp.
Schmieg, Martin
4 - Director of Issuer
Direct Ownership
Options
50 - Grant of options
$75,000
+500,000 vol
$0.15 each
500,000
Filed 2018-03-08
Tx date 2016-05-10
$BCT
BriaCell Therapeutics Corp.
Schmieg, Martin
4 - Director of Issuer
Direct Ownership
Options
00 - Opening Balance-Initial SEDI Report
Filed 2018-03-08
Tx date 2016-05-10
$BCT
BriaCell Therapeutics Corp.
Schmieg, Martin
4 - Director of Issuer
Direct Ownership
Options
00 - Opening Balance-Initial SEDI Report
Filed 2018-03-08
Tx date 2016-05-10
$BCT
BriaCell Therapeutics Corp.
Schmieg, Martin
4 - Director of Issuer
Direct Ownership
Options
00 - Opening Balance-Initial SEDI Report
Filed 2018-03-08
Tx date 2016-05-10
$BCT
BriaCell Therapeutics Corp.
Schmieg, Martin
4 - Director of Issuer
Direct Ownership
Options
00 - Opening Balance-Initial SEDI Report
Filed 2018-03-08
Tx date 2016-05-09
$BCT
BriaCell Therapeutics Corp.
Schmieg, Martin
4 - Director of Issuer
Direct Ownership
Options
50 - Grant of options
$127,500
+500,000 vol
$0.255 each
Filed 2018-03-02
Tx date 2018-03-01
$BCT
BriaCell Therapeutics Corp.
SHARAN, RAHOUL
4 - Director of Issuer
Direct Ownership
Options
50 - Grant of options
$75,000
+500,000 vol
$0.15 each
700,000
Filed 2018-03-02
Tx date 2018-03-01
$BCT
BriaCell Therapeutics Corp.
Babaei, Saeid
4 - Director of Issuer
Direct Ownership
Options
50 - Grant of options
$75,000
+500,000 vol
$0.15 each
1,250,000
Filed 2018-03-02
Tx date 2018-03-01
$BCT
BriaCell Therapeutics Corp.
Lacher, Markus Daniel
5 - Senior Officer of Issuer
Direct Ownership
Options
00 - Opening Balance-Initial SEDI Report
500,000
Filed 2018-03-02
Tx date 2018-03-01
$BCT
BriaCell Therapeutics Corp.
Lacher, Markus Daniel
5 - Senior Officer of Issuer
Direct Ownership
Options
50 - Grant of options
$15,000
+100,000 vol
$0.15 each
600,000
Filed 2018-03-02
Tx date 2018-03-01
$BCT
BriaCell Therapeutics Corp.
WILLIAMS, WILLIAM
4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
Options
50 - Grant of options
$112,500
+750,000 vol
$0.15 each
1,382,000
Filed 2018-03-02
Tx date 2018-02-28
$BCT
BriaCell Therapeutics Corp.
WISEMAN, CHARLES LOUIS
6 - Director or Senior Officer of 10% Security Holder
Direct Ownership
Options
52 - Expiration of options

-500,000 vol
0
Filed 2018-03-02
Tx date 2018-03-01
$BCT
BriaCell Therapeutics Corp.
WISEMAN, CHARLES LOUIS
6 - Director or Senior Officer of 10% Security Holder
Direct Ownership
Options
50 - Grant of options
$75,000
+500,000 vol
$0.15 each
500,000
Filed 2018-03-01
Tx date 2018-01-15
$BCT
BriaCell Therapeutics Corp.
Levin, Gadi
5 - Senior Officer of Issuer
Direct Ownership
Options
52 - Expiration of options
$-51,000
-200,000 vol
$0.255 each
0
Filed 2018-03-01
Tx date 2018-03-01
$BCT
BriaCell Therapeutics Corp.
Levin, Gadi
5 - Senior Officer of Issuer
Direct Ownership
Options
50 - Grant of options
$30,000
+200,000 vol
$0.15 each
200,000
Filed 2018-03-01
Tx date 2018-01-15
$BCT
BriaCell Therapeutics Corp.
Levin, Gadi
5 - Senior Officer of Issuer
Direct Ownership
Options
52 - Expiration of options
$51,000
+200,000 vol
$0.255 each
Filed 2018-02-27
Tx date 2018-02-27
$BCT
BriaCell Therapeutics Corp.
Babaei, Saeid
4 - Director of Issuer
Direct Ownership
Options
52 - Expiration of options

-500,000 vol
750,000
Filed 2018-02-27
Tx date 2018-02-27
$BCT
BriaCell Therapeutics Corp.
SHARAN, RAHOUL
4 - Director of Issuer
Direct Ownership
Options
52 - Expiration of options

-500,000 vol
200,000
Filed 2017-12-03
Tx date 2017-12-01
$BCT
BriaCell Therapeutics Corp.
SHARAN, RAHOUL
4 - Director of Issuer
Direct Ownership
Common Shares
10 - Acquisition or disposition in the public market
$65.00
+500 vol
$0.13 each
1,240,378
Filed 2017-12-03
Tx date 2017-12-01
$BCT
BriaCell Therapeutics Corp.
SHARAN, RAHOUL
4 - Director of Issuer
Direct Ownership
Common Shares
10 - Acquisition or disposition in the public market
$3,250
+25,000 vol
$0.13 each
1,239,878
Filed 2017-11-17
Tx date 2017-11-16
$BCT
BriaCell Therapeutics Corp.
SHARAN, RAHOUL
4 - Director of Issuer
Direct Ownership
Common Shares
10 - Acquisition or disposition in the public market
$650.00
+5,000 vol
$0.13 each
1,214,878
Filed 2017-11-15
Tx date 2017-11-15
$BCT
BriaCell Therapeutics Corp.
SHARAN, RAHOUL
4 - Director of Issuer
Direct Ownership
Common Shares
10 - Acquisition or disposition in the public market
$3,675
+24,500 vol
$0.15 each
1,209,878
Filed 2017-11-15
Tx date 2017-11-14
$BCT
BriaCell Therapeutics Corp.
SHARAN, RAHOUL
4 - Director of Issuer
Direct Ownership
Common Shares
10 - Acquisition or disposition in the public market
$1,600
+10,000 vol
$0.16 each
1,185,378
Filed 2017-10-05
Tx date 2017-10-04
$BCT
BriaCell Therapeutics Corp.
SHARAN, RAHOUL
4 - Director of Issuer
Direct Ownership
Common Shares
10 - Acquisition or disposition in the public market
$1,350
+10,000 vol
$0.135 each
1,175,378
Filed 2017-09-17
Tx date 2017-08-21
$BCT
BriaCell Therapeutics Corp.
WILLIAMS, WILLIAM
4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
Common Shares
22 - Acquisition or disposition pursuant to a take-over bid, merger or acquisition
$162,125
+1,013,283 vol
$0.16 each
10,802,249
Filed 2017-09-17
Tx date 2017-08-21
$BCT
BriaCell Therapeutics Corp.
WILLIAMS, WILLIAM
4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
Common Shares
22 - Acquisition or disposition pursuant to a take-over bid, merger or acquisition
$198,125
+1,238,283 vol
$0.16 each
Filed 2017-09-01
Tx date 2017-09-01
$BCT
BriaCell Therapeutics Corp.
SHARAN, RAHOUL
4 - Director of Issuer
Direct Ownership
Common Shares
10 - Acquisition or disposition in the public market
$8,250
+50,000 vol
$0.165 each
1,165,378
Filed 2017-09-01
Tx date 2017-09-01
$BCT
BriaCell Therapeutics Corp.
SHARAN, RAHOUL
4 - Director of Issuer
Direct Ownership
Common Shares
10 - Acquisition or disposition in the public market
$3,200
+20,000 vol
$0.16 each
1,115,378
Filed 2017-08-28
Tx date 2017-08-28
$BCT
BriaCell Therapeutics Corp.
SHARAN, RAHOUL
4 - Director of Issuer
Direct Ownership
Common Shares
10 - Acquisition or disposition in the public market
$8,000
+50,000 vol
$0.16 each
1,095,378
Filed 2017-08-22
Tx date 2016-05-10
$BCT
BriaCell Therapeutics Corp.
Schmieg, Martin
4 - Director of Issuer
Direct Ownership
Common Shares
00 - Opening Balance-Initial SEDI Report
Filed 2017-08-22
Tx date 2017-08-21
$BCT
BriaCell Therapeutics Corp.
WILLIAMS, WILLIAM
4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
Common Shares
22 - Acquisition or disposition pursuant to a take-over bid, merger or acquisition
$198,125
+1,238,283 vol
$0.16 each
11,027,249
Filed 2017-08-22
Tx date 2017-08-21
$BCT
BriaCell Therapeutics Corp.
Schmieg, Martin
4 - Director of Issuer
Direct Ownership
Common Shares
22 - Acquisition or disposition pursuant to a take-over bid, merger or acquisition
$11,582
+72,391 vol
$0.16 each
72,391
Filed 2017-08-17
Tx date 2017-08-15
$BCT
BriaCell Therapeutics Corp.
SHARAN, RAHOUL
4 - Director of Issuer
Direct Ownership
Common Shares
10 - Acquisition or disposition in the public market
$-32,000
-200,000 vol
$0.16 each
1,045,378
Filed 2017-08-10
Tx date 2017-08-10
$BCT
BriaCell Therapeutics Corp.
SHARAN, RAHOUL
4 - Director of Issuer
Direct Ownership
Common Shares
10 - Acquisition or disposition in the public market
$480.00
+3,000 vol
$0.16 each
1,243,378
Filed 2017-08-10
Tx date 2017-08-09
$BCT
BriaCell Therapeutics Corp.
WILLIAMS, WILLIAM
4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
Common Shares
11 - Acquisition or disposition carried out privately
$649,350
+4,058,441 vol
$0.16 each
9,788,966
Filed 2017-08-10
Tx date 2017-08-10
$BCT
BriaCell Therapeutics Corp.
SHARAN, RAHOUL
4 - Director of Issuer
Direct Ownership
Common Shares
10 - Acquisition or disposition in the public market
$320.00
+2,000 vol
$0.16 each
1,245,378
Filed 2017-08-08
Tx date 2017-08-04
$BCT
BriaCell Therapeutics Corp.
SHARAN, RAHOUL
4 - Director of Issuer
Direct Ownership
Common Shares
10 - Acquisition or disposition in the public market
$1,600
+10,000 vol
$0.16 each
1,240,378
Filed 2017-08-03
Tx date 2017-08-02
$BCT
BriaCell Therapeutics Corp.
SHARAN, RAHOUL
4 - Director of Issuer
Direct Ownership
Common Shares
10 - Acquisition or disposition in the public market
$80.00
+500 vol
$0.16 each
1,228,378
Filed 2017-08-03
Tx date 2017-08-03
$BCT
BriaCell Therapeutics Corp.
SHARAN, RAHOUL
4 - Director of Issuer
Direct Ownership
Common Shares
10 - Acquisition or disposition in the public market
$320.00
+2,000 vol
$0.16 each
1,230,378
Filed 2017-07-28
Tx date 2017-07-27
$BCT
BriaCell Therapeutics Corp.
SHARAN, RAHOUL
4 - Director of Issuer
Direct Ownership
Common Shares
10 - Acquisition or disposition in the public market
$247.50
+1,500 vol
$0.165 each
1,227,878
Filed 2017-07-18
Tx date 2017-07-17
$BCT
BriaCell Therapeutics Corp.
SHARAN, RAHOUL
4 - Director of Issuer
Direct Ownership
Common Shares
10 - Acquisition or disposition in the public market
$247.50
+1,500 vol
$0.165 each
1,226,378
Filed 2017-07-17
Tx date 2017-07-17
$BCT
BriaCell Therapeutics Corp.
SHARAN, RAHOUL
4 - Director of Issuer
Direct Ownership
Common Shares
10 - Acquisition or disposition in the public market
$577.50
+3,500 vol
$0.165 each
1,224,878
Filed 2017-05-01
Tx date 2017-04-27
$BCT
BriaCell Therapeutics Corp.
Maresky, Isaac Benjamin
4 - Director of Issuer
Direct Ownership
Common Shares
16 - Acquisition or disposition under a prospectus exemption
$36,000
+720,000 vol
$0.05 each
768,000
Filed 2017-05-01
Tx date 2017-04-27
$BCT
BriaCell Therapeutics Corp.
Maresky, Isaac Benjamin
4 - Director of Issuer
Direct Ownership
Options
50 - Grant of options
$22,050
+315,000 vol
$0.07 each
1,315,000
Filed 2017-03-29
Tx date 2017-03-28
$BCT
BriaCell Therapeutics Corp.
WILLIAMS, WILLIAM
4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
Warrants
53 - Grant of warrants
$1,964,229
+5,612,083 vol
$0.35 each
Filed 2017-03-29
Tx date 2017-03-28
$BCT
BriaCell Therapeutics Corp.
WILLIAMS, WILLIAM
4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
Warrants
53 - Grant of warrants
$982,114
+2,806,041 vol
$0.35 each
2,806,041
Filed 2017-03-29
Tx date 2017-03-28
$BCT
BriaCell Therapeutics Corp.
WILLIAMS, WILLIAM
4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
Warrants
53 - Grant of warrants
$1,964,229
+5,612,083 vol
$0.35 each
Filed 2017-03-28
Tx date 2017-01-18
$BCT
BriaCell Therapeutics Corp.
WILLIAMS, WILLIAM
4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
Common Shares
10 - Acquisition or disposition in the public market
$8,307
+57,292 vol
$0.145 each
57,292
Filed 2017-03-28
Tx date 2017-03-28
$BCT
BriaCell Therapeutics Corp.
WILLIAMS, WILLIAM
4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
Warrants
53 - Grant of warrants
$1,964,229
+5,612,083 vol
$0.35 each
5,612,083
Filed 2017-03-28
Tx date 2016-11-01
$BCT
BriaCell Therapeutics Corp.
WILLIAMS, WILLIAM
4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
Warrants
00 - Opening Balance-Initial SEDI Report
Filed 2017-03-28
Tx date 2017-03-28
$BCT
BriaCell Therapeutics Corp.
WILLIAMS, WILLIAM
4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
Common Shares
11 - Acquisition or disposition carried out privately
$1,346,899
+5,612,083 vol
$0.24 each
5,730,525
Filed 2017-03-28
Tx date 2017-01-18
$BCT
BriaCell Therapeutics Corp.
WILLIAMS, WILLIAM
4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
Common Shares
10 - Acquisition or disposition in the public market
$3,957
+27,292 vol
$0.145 each
Filed 2017-03-15
Tx date 2017-03-15
$BCT
BriaCell Therapeutics Corp.
SHARAN, RAHOUL
4 - Director of Issuer
Direct Ownership
Common Shares
10 - Acquisition or disposition in the public market
$5,500
+25,000 vol
$0.22 each
1,221,378
Filed 2017-03-09
Tx date 2017-03-09
$BCT
BriaCell Therapeutics Corp.
SHARAN, RAHOUL
4 - Director of Issuer
Direct Ownership
Common Shares
10 - Acquisition or disposition in the public market
$1,380
+6,000 vol
$0.23 each
1,196,378
Filed 2017-03-01
Tx date 2017-01-18
$BCT
BriaCell Therapeutics Corp.
WILLIAMS, WILLIAM
4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
Common Shares
10 - Acquisition or disposition in the public market
$3,957
+27,292 vol
$0.145 each
27,292
Filed 2017-03-01
Tx date 2017-02-23
$BCT
BriaCell Therapeutics Corp.
WILLIAMS, WILLIAM
4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
Common Shares
10 - Acquisition or disposition in the public market
$7,000
+50,000 vol
$0.14 each
88,442
Filed 2017-03-01
Tx date 2017-01-20
$BCT
BriaCell Therapeutics Corp.
WILLIAMS, WILLIAM
4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
Common Shares
10 - Acquisition or disposition in the public market
$1,672
+11,150 vol
$0.15 each
38,442
Filed 2017-03-01
Tx date 2016-11-01
$BCT
BriaCell Therapeutics Corp.
WILLIAMS, WILLIAM
4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
Common Shares
00 - Opening Balance-Initial SEDI Report
Filed 2017-02-28
Tx date 2017-02-28
$BCT
BriaCell Therapeutics Corp.
SHARAN, RAHOUL
4 - Director of Issuer
Direct Ownership
Common Shares
10 - Acquisition or disposition in the public market
$-5,945
-29,000 vol
$0.205 each
1,190,378
Filed 2017-02-28
Tx date 2017-02-28
$BCT
BriaCell Therapeutics Corp.
SHARAN, RAHOUL
4 - Director of Issuer
Direct Ownership
Common Shares
10 - Acquisition or disposition in the public market
$-4,515
-21,000 vol
$0.215 each
1,219,378
Filed 2017-02-17
Tx date 2017-02-17
$BCT
BriaCell Therapeutics Corp.
SHARAN, RAHOUL
4 - Director of Issuer
Direct Ownership
Common Shares
10 - Acquisition or disposition in the public market
$5,250
+25,000 vol
$0.21 each
1,240,378
Filed 2017-02-10
Tx date 2017-02-09
$BCT
BriaCell Therapeutics Corp.
SHARAN, RAHOUL
4 - Director of Issuer
Direct Ownership
Common Shares
10 - Acquisition or disposition in the public market
$4,250
+25,000 vol
$0.17 each
1,215,378
Filed 2017-02-07
Tx date 2017-02-07
$BCT
BriaCell Therapeutics Corp.
SHARAN, RAHOUL
4 - Director of Issuer
Direct Ownership
Common Shares
10 - Acquisition or disposition in the public market
$3,230
+19,000 vol
$0.17 each
1,186,378
Filed 2017-02-07
Tx date 2017-02-07
$BCT
BriaCell Therapeutics Corp.
SHARAN, RAHOUL
4 - Director of Issuer
Direct Ownership
Common Shares
10 - Acquisition or disposition in the public market
$680.00
+4,000 vol
$0.17 each
1,190,378
Filed 2017-02-07
Tx date 2017-02-07
$BCT
BriaCell Therapeutics Corp.
SHARAN, RAHOUL
4 - Director of Issuer
Direct Ownership
Common Shares
10 - Acquisition or disposition in the public market
$340.00
+2,000 vol
$0.17 each
1,167,378
Filed 2017-01-11
Tx date 2017-01-10
$BCT
BriaCell Therapeutics Corp.
SHARAN, RAHOUL
4 - Director of Issuer
Direct Ownership
Common Shares
10 - Acquisition or disposition in the public market
$760.00
+4,000 vol
$0.19 each
1,165,378
Filed 2016-11-22
Tx date 2016-11-18
$BCT
BriaCell Therapeutics Corp.
SHARAN, RAHOUL
4 - Director of Issuer
Holder: KJN Management Ltd (Indirect Ownership)
Common Shares
10 - Acquisition or disposition in the public market
$4,560
+28,500 vol
$0.16 each
81,500
Filed 2016-11-22
Tx date 2016-11-21
$BCT
BriaCell Therapeutics Corp.
SHARAN, RAHOUL
4 - Director of Issuer
Holder: KJN Management Ltd (Indirect Ownership)
Common Shares
10 - Acquisition or disposition in the public market
$320.00
+2,000 vol
$0.16 each
89,000
Filed 2016-11-22
Tx date 2016-11-18
$BCT
BriaCell Therapeutics Corp.
SHARAN, RAHOUL
4 - Director of Issuer
Holder: KJN Management Ltd (Indirect Ownership)
Common Shares
10 - Acquisition or disposition in the public market
$797.50
+5,500 vol
$0.145 each
87,000
Filed 2016-11-22
Tx date 2016-11-18
$BCT
BriaCell Therapeutics Corp.
SHARAN, RAHOUL
4 - Director of Issuer
Holder: KJN Management Ltd (Indirect Ownership)
Common Shares
10 - Acquisition or disposition in the public market
$7,974
+55,000 vol
$0.145 each
Filed 2016-11-22
Tx date 2016-11-18
$BCT
BriaCell Therapeutics Corp.
SHARAN, RAHOUL
4 - Director of Issuer
Holder: KJN Management Ltd (Indirect Ownership)
Common Shares
10 - Acquisition or disposition in the public market
$150.00
+1,000 vol
$0.15 each
53,000
Filed 2016-11-03
Tx date 2016-11-01
$BCT
BriaCell Therapeutics Corp.
WILLIAMS, WILLIAM
4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
Options
00 - Opening Balance-Initial SEDI Report
632,000
Filed 2016-10-17
Tx date 2016-10-17
$BCT
BriaCell Therapeutics Corp.
WISEMAN, CHARLES LOUIS
4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
Common Shares
10 - Acquisition or disposition in the public market
$-104,300
-521,500 vol
$0.20 each
13,311,287
Filed 2016-10-17
Tx date 2016-10-17
$BCT
BriaCell Therapeutics Corp.
WISEMAN, CHARLES LOUIS
4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
Common Shares
10 - Acquisition or disposition in the public market
$-5,842.50
-28,500 vol
$0.205 each
13,832,787
Filed 2016-10-17
Tx date 2016-10-17
$BCT
BriaCell Therapeutics Corp.
WISEMAN, CHARLES LOUIS
4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
Common Shares
10 - Acquisition or disposition in the public market
$-210.00
-1,000 vol
$0.21 each
13,861,287
Filed 2016-10-17
Tx date 2016-10-13
$BCT
BriaCell Therapeutics Corp.
WISEMAN, CHARLES LOUIS
4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
Common Shares
10 - Acquisition or disposition in the public market
$-1,947.50
-9,500 vol
$0.205 each
13,862,287
Filed 2016-09-27
Tx date 2016-05-09
$BCT
BriaCell Therapeutics Corp.
Schmieg, Martin
4 - Director of Issuer
Direct Ownership
Options
50 - Grant of options
$127,500
+500,000 vol
$0.255 each
500,000
Filed 2016-08-10
Tx date 2016-08-10
$BCT
BriaCell Therapeutics Corp.
SHARAN, RAHOUL
4 - Director of Issuer
Direct Ownership
Common Shares
10 - Acquisition or disposition in the public market
$2,925
+13,000 vol
$0.225 each
1,161,378
Filed 2016-08-05
Tx date 2016-08-05
$BCT
BriaCell Therapeutics Corp.
SHARAN, RAHOUL
4 - Director of Issuer
Direct Ownership
Common Shares
10 - Acquisition or disposition in the public market
$1,505
+7,000 vol
$0.215 each
1,143,378
Filed 2016-08-05
Tx date 2016-08-05
$BCT
BriaCell Therapeutics Corp.
SHARAN, RAHOUL
4 - Director of Issuer
Direct Ownership
Common Shares
10 - Acquisition or disposition in the public market
$1,075
+5,000 vol
$0.215 each
1,148,378
Filed 2016-06-20
Tx date 2016-05-10
$BCT
BriaCell Therapeutics Corp.
Schmieg, Martin
4 - Director of Issuer
Direct Ownership
Options
00 - Opening Balance-Initial SEDI Report
Filed 2016-06-20
Tx date 2016-05-10
$BCT
BriaCell Therapeutics Corp.
Schmieg, Martin
4 - Director of Issuer
Direct Ownership
Options
00 - Opening Balance-Initial SEDI Report
Filed 2016-06-14
Tx date 2016-05-27
$BCT
BriaCell Therapeutics Corp.
Levin, Gadi
5 - Senior Officer of Issuer
Direct Ownership
Options
50 - Grant of options
$51,000
+200,000 vol
$0.255 each
200,000
Filed 2016-04-29
Tx date 2006-07-27
$BCT
BriaCell Therapeutics Corp.
SHARAN, RAHOUL
4 - Director of Issuer
Direct Ownership
Warrants
00 - Opening Balance-Initial SEDI Report
Filed 2016-04-29
Tx date 2016-04-29
$BCT
BriaCell Therapeutics Corp.
SHARAN, RAHOUL
4 - Director of Issuer
Direct Ownership
Warrants
11 - Acquisition or disposition carried out privately

+175,000 vol
175,000
Filed 2016-04-29
Tx date 2016-04-29
$BCT
BriaCell Therapeutics Corp.
SHARAN, RAHOUL
4 - Director of Issuer
Direct Ownership
Common Shares
11 - Acquisition or disposition carried out privately
$140,000
+700,000 vol
$0.20 each
1,136,378
Filed 2016-04-25
Tx date 2016-04-22
$BCT
BriaCell Therapeutics Corp.
SHARAN, RAHOUL
4 - Director of Issuer
Direct Ownership
Common Shares
10 - Acquisition or disposition in the public market
$-140,000
-700,000 vol
$0.20 each
436,378
Filed 2016-03-29
Tx date 2016-02-01
$BCT
BriaCell Therapeutics Corp.
Levin, Gadi
5 - Senior Officer of Issuer
Direct Ownership
Warrants
00 - Opening Balance-Initial SEDI Report
Filed 2016-03-29
Tx date 2016-02-01
$BCT
BriaCell Therapeutics Corp.
Levin, Gadi
5 - Senior Officer of Issuer
Direct Ownership
Common Shares
00 - Opening Balance-Initial SEDI Report
Filed 2016-03-29
Tx date 2016-02-01
$BCT
BriaCell Therapeutics Corp.
Levin, Gadi
5 - Senior Officer of Issuer
Direct Ownership
Options
00 - Opening Balance-Initial SEDI Report
Filed 2016-01-27
Tx date 2016-01-25
$BCT
BriaCell Therapeutics Corp.
WISEMAN, CHARLES LOUIS
4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
Common Shares
11 - Acquisition or disposition carried out privately
$-17,500
-70,000 vol
$0.25 each
13,871,787
Filed 2016-01-27
Tx date 2016-01-25
$BCT
BriaCell Therapeutics Corp.
WISEMAN, CHARLES LOUIS
4 - Director of Issuer, 5 - Senior Officer of Issuer
Holder: Wiseman Cancer Research Foundation (Indirect Ownership)
Common Shares
11 - Acquisition or disposition carried out privately
$17,500
+70,000 vol
$0.25 each
70,000
Filed 2016-01-27
Tx date 2014-11-25
$BCT
BriaCell Therapeutics Corp.
WISEMAN, CHARLES LOUIS
4 - Director of Issuer, 5 - Senior Officer of Issuer
Holder: Wiseman Cancer Research Foundation (Indirect Ownership)
Common Shares
00 - Opening Balance-Initial SEDI Report
Filed 2015-12-21
Tx date 2015-12-10
$BCT
BriaCell Therapeutics Corp.
Wagner, Joseph Paul
4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
Common Shares
10 - Acquisition or disposition in the public market
$819.50
+5,000 vol
$0.1639 each
30,000
Filed 2015-12-07
Tx date 2015-12-07
$BCT
BriaCell Therapeutics Corp.
Wagner, Joseph Paul
4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
Common Shares
10 - Acquisition or disposition in the public market
$862.50
+5,000 vol
$0.1725 each
20,000
Filed 2015-12-07
Tx date 2015-12-07
$BCT
BriaCell Therapeutics Corp.
Wagner, Joseph Paul
4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
Common Shares
10 - Acquisition or disposition in the public market
$841.50
+5,000 vol
$0.1683 each
15,000
Filed 2015-12-07
Tx date 2015-12-04
$BCT
BriaCell Therapeutics Corp.
Wagner, Joseph Paul
4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
Common Shares
10 - Acquisition or disposition in the public market
$783.00
+4,500 vol
$0.174 each
10,000
Filed 2015-12-07
Tx date 2015-12-04
$BCT
BriaCell Therapeutics Corp.
Wagner, Joseph Paul
4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
Common Shares
10 - Acquisition or disposition in the public market
$751.05
+4,500 vol
$0.1669 each
5,500
Filed 2015-12-07
Tx date 2015-12-07
$BCT
BriaCell Therapeutics Corp.
Wagner, Joseph Paul
4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
Common Shares
10 - Acquisition or disposition in the public market
$861.50
+5,000 vol
$0.1723 each
25,000
Filed 2015-12-07
Tx date 2015-12-04
$BCT
BriaCell Therapeutics Corp.
Wagner, Joseph Paul
4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
Common Shares
10 - Acquisition or disposition in the public market
$83.30
+500 vol
$0.1666 each
1,000
Filed 2015-12-07
Tx date 2015-12-04
$BCT
BriaCell Therapeutics Corp.
Wagner, Joseph Paul
4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
Common Shares
10 - Acquisition or disposition in the public market
$81.60
+500 vol
$0.1632 each
500
Filed 2015-12-07
Tx date 2015-06-01
$BCT
BriaCell Therapeutics Corp.
Wagner, Joseph Paul
4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
Common Shares
00 - Opening Balance-Initial SEDI Report
Filed 2015-11-06
Tx date 2015-11-04
$BCT
BriaCell Therapeutics Corp.
WRIGHT, MATTHEW GEORGE
5 - Senior Officer of Issuer
Direct Ownership
Options
50 - Grant of options
$6,375
+25,000 vol
$0.255 each
100,000
Filed 2015-11-05
Tx date 2015-11-04
$BCT
BriaCell Therapeutics Corp.
Babaei, Saeid
4 - Director of Issuer
Direct Ownership
Options
50 - Grant of options
$191,250
+750,000 vol
$0.255 each
1,250,000
Filed 2015-11-05
Tx date 2015-11-04
$BCT
BriaCell Therapeutics Corp.
Maresky, Isaac Benjamin
4 - Director of Issuer
Direct Ownership
Options
50 - Grant of options
$127,500
+500,000 vol
$0.255 each
1,000,000
Filed 2015-11-05
Tx date 2015-11-04
$BCT
BriaCell Therapeutics Corp.
Wagner, Joseph Paul
4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
Options
50 - Grant of options
$255,000
+1,000,000 vol
$0.255 each
1,000,000
Filed 2015-11-05
Tx date 2015-11-04
$BCT
BriaCell Therapeutics Corp.
SHARAN, RAHOUL
4 - Director of Issuer
Direct Ownership
Options
50 - Grant of options
$51,000
+200,000 vol
$0.255 each
700,000
Filed 2015-11-05
Tx date 2015-06-01
$BCT
BriaCell Therapeutics Corp.
Wagner, Joseph Paul
4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
Options
00 - Opening Balance-Initial SEDI Report
Filed 2015-06-30
Tx date 2015-06-30
$BCT
BriaCell Therapeutics Corp.
SHARAN, RAHOUL
4 - Director of Issuer
Direct Ownership
Common Shares
10 - Acquisition or disposition in the public market
$6,000
+25,000 vol
$0.24 each
1,136,378
Filed 2015-06-11
Tx date 2015-06-10
$BCT
BriaCell Therapeutics Corp.
SHARAN, RAHOUL
4 - Director of Issuer
Direct Ownership
Common Shares
10 - Acquisition or disposition in the public market
$6,500
+25,000 vol
$0.26 each
1,111,378
Filed 2015-05-08
Tx date 2015-05-06
$BCT
BriaCell Therapeutics Corp.
SHARAN, RAHOUL
4 - Director of Issuer
Direct Ownership
Common Shares
10 - Acquisition or disposition in the public market
$33,000
+100,000 vol
$0.33 each
1,086,378
Filed 2015-05-05
Tx date 2015-05-04
$BCT
BriaCell Therapeutics Corp.
SHARAN, RAHOUL
4 - Director of Issuer
Direct Ownership
Common Shares
10 - Acquisition or disposition in the public market
$-64,600
-190,000 vol
$0.34 each
987,070
Filed 2015-05-05
Tx date 2015-05-04
$BCT
BriaCell Therapeutics Corp.
SHARAN, RAHOUL
4 - Director of Issuer
Direct Ownership
Common Shares
10 - Acquisition or disposition in the public market
$-231.82
-692 vol
$0.335 each
986,378
Filed 2014-01-24
Tx date 2014-01-24
$BCT
Ansell Capital Corp.
SHARAN, RAHOUL
4 - Director of Issuer
Direct Ownership
Common Shares
10 - Acquisition or disposition in the public market
$3,430
+98,000 vol
$0.035 each
3,701,166